Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention

Academic Medicine

Volumn 81, Issue 7, 2006, Pages 595-602

  Schneider, John A ^a,e   Arora, Vineet ^a,b   Kasza, Kristen ^a   Van Harrison, R ^c   Humphrey, Holly ^d  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; DATA ANALYSIS; DRUG INDUSTRY; GIFT GIVING; HUMAN; INSTITUTIONAL ETHICS; LINEAR REGRESSION ANALYSIS; PHYSICIAN ATTITUDE; POLICY; PRIORITY JOURNAL; QUESTIONNAIRE; RESIDENCY EDUCATION; RESIDENT; UNITED STATES; UNIVERSITY HOSPITAL; WORKSHOP;

EID: 33747706740     PISSN: 10402446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ACM.0000232408.12648.5a     Document Type: Article

References (33)

1. Ethical guidelines for gifts to physicians from industry (http://www.ama-assn.org/ama/pub/category/5689.html). Accessed 22 March 2006. American Medical Association.
2. Coyle SL. Physician-industry relations. Part 1: individual physicians. Ann Intern Med. 2002;136:396-402.
3. Standards For Commercial Support (http://www.accme.org/dir_docs/ doc_upload/68b2902a-fb73-44d1-8725-80a1504e520c_uploaddocument.pdf). Accessed 22 March 2006. Accreditation Council for Continuing Medical Education.
4. Principles Regarding Pharmaceuticals and Medical Devices (http://www.amsa.org/hp/pharmpolicy.cfm). Accessed 22 March 2006. American Medical Student Association.
5. Goodman B. No Free Lunch (http://www.nofreelunch.org/). Accessed22 March 2006.
6. PhRMA Code on Interactions With Healthcare Professionals (http://www.phrma.org/files/PhRMA%20Code.pdf). Accessed 26 March 2006. Pharmaceutical Research and Manufacturers of America.
7. Lichstein PR, Turner RC, O'Brien K. Impact of pharmaceutical company representatives on internal medicine residency programs: a survey of residency program directors. Arch Intern Med. Jun. 1992;152:1009-13.
8. Boltri JM, Gordon ER, Vogel RL. Effect of antihypertensive samples on physician prescribing patterns. Fam Med. 2002;34:729-31.
9. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283:373-80.
10. Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med. 2003;163:2213-18.
11. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA. 2003;290:252-55.
12. Principles to Guide the Relationship Between Graduate Medical Education and Industry (http://www.acgme.org/acWebsite/positionPapers/pp_GMEGuide.pdf). Accessed 22 March 2006. Accreditation Council for Graduate Medical Education.
13. Brotzman GL, Mark DH. The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. J Gen Intern Med. 1993;8:130-34.
14. Keim SM, Sanders AB, Witzke DB, Dyne P, Fulginiti JW. Beliefs and practices of emergency medicine faculty and residents regarding professional interactions with the biomedical industry. Ann Emerg Med. 1993;22:1576-81.
15. Reeder M, Dougherty J, White LJ. Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med. 1993;22:1593-96.
16. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 2001;110:551-57.
17. Lurie N, Rich EC, Simpson DE, et al. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med. 1990;5:240-43.
18. Orlowski JP, Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch. Chest. 1992;102:270-73.
19. Hafferty FW. Beyond curriculum reform: confronting medicine's hidden curriculum. Acad Med. 1998;73:403-7.
20. Ferguson RP, Rhim E, Belizaire W, Egede L, Carter K, Lansdale T. Encounters with pharmaceutical sales representatives among practicing internists. Am J Med. 1999;107:149-52.
21. McCormick BB, Tomlinson G, Brill-Edwards P, Detsky AS. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA. 2001;286:1994-99.
22. Watkins RS, Kimberly J Jr. What residents don't know about physician-pharmaceutical industry interactions. Acad Med. 2004;79:432-37.
23. Razack S, Arbour L, Hutcheon R. Proposed model for interaction between residents and residency training programs, and pharmaceutical industry. Ann R Coll Physicians Surg Can. 1999;32:93-96.
24. Agrawal S, Saluja I, Kaczorowski J. A prospective before-and-after trial of an educational intervention about pharmaceutical marketing. Acad Med. 2004;79:1046-50.
25. Hopper JA, Speece MW, Musial JL. Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives. J Gen Intern Med. 1997;12:639-42.
26. Kelcher S, Brownoff R, Meadows LM. Structured approach to pharmaceutical representatives: family medicine residency program. Can Fam Physician. 1998;44:1053-56, 1059-60.
27. Shaughnessy AF, Slawson DC, Bennett JH. Teaching information mastery: evaluating information provided by pharmaceutical representatives. Fam Med. 1995;27:581-85.
28. Ethical Opinions and Guidelines. Vol 2005;2001 (http://www.ama-assn.org/ ama/pub/category/4001.html). Accessed 22 March 2006.
29. Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. CMAJ. 1995;153:553-59.
30. Residents and the Pharmaceutical Industry. Dartmouth Fall Invitational Clinical Microsystems Conference Film Festival. Hanover, New Hampshire, 2003.
31. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Erlbaum, 1988.
32. Bellin M, McCarthy S, Drevlow L, Pierach C. Medical students' exposure to pharmaceutical industry marketing: a survey at one U.S. medical school. Acad Med. 2004;79:1041-45.
33. Sierles FS, Brodkey AC, Cleary LM, et al. Medical students' exposure to and attitudes about drug company interactions: a national survey. JAMA. 2005;294:1034-42.